Switzer TV

 

The year is winding down, but markets aren't. This week we put some of the market’s biggest names under the microscope. Fairmont Equities’ Michael Gable joins Paul Rickard to break down the technical and fundamental signals across Aussie blue chips and resource giants — including Rio, South32, CSL, Pro Medicus, and more.

Then Peter Switzer is joined by Morgans’ Chief Economist Michael Knox, who lays out a bold prediction for interest rates in 2026 — and why electricity supply, not demand, could be the biggest inflation driver next year.

Subscribe so you don’t miss future episodes.

Switzer Investing TV (08/12/25): Superstar stocks under the microscope | Morgans chief economist predicts 2026 market

The year is winding down, but markets aren't. This week we put some of the market’s biggest names under the microscope.

More videos

Mad about Money

Get your weekly insights from Peter Switzer and Paul Rickard regarding the latest money stories and market trends.

Series:
7 quality stocks with heaps of upside: XRO, DMP, A2M & more + how fund managers pick hot stocks!

Peter Switzer is joined by Julia Lee of Burman Invest, Jun Bei Liu of Tribeca Alpha Plus Fund, and Paul Rickard from the Switzer Report.

Series:
Dr Ross gives a deep dive into the condition called frailty | The Check Up

Dr Ross breaks down the acronym of FRAIL; discussing the symptoms of this condition and the repercussions that come with it.

Series:
Fund Manager David Allingham reveals his hot small cap stocks + why house prices won’t fall 25%

Peter Switzer is joined by David Allingham of Eley Griffiths, Charlie Aitkin of Aitkin Investment Management, and Nicola Powell, Chief Economist at Domain.

Series:
Mad about Money

Get your weekly insights from Peter Switzer and Paul Rickard regarding the latest money stories and market trends.

Series:
Can these stocks rebound? Appen, A2Milk, Mesoblast, Lend Lease, PushPay, Splitit and Nuix

Peter Switzer is joined by Julia Lee of Burman Invest, Adam Dawes of Shaw and Partners, and Paul Rickard from the Switzer Report.

Series:
Putting COVID-19 into perspective | The Check Up

Dr Ross puts COVID-19 into perspective, explaining that the real killers are cancer and heart disease.

Series:
5 tech stocks with upside: Megaport, Audinate, ELO, & more + will house prices slump 20%?

Peter Switzer is joined by Michael Wayne of Medallion Financial, Marcus Bogdan of Blackmore Capital, Chris Joye of Coolabah Capital, and Paul Miron of MSquared Capital.

Series:
Mad about Money

Will oil companies beat climate change pressures, is freedom one week away for NSW but what about the rest of Australia, and interest rates to rise with the RBA in retreat.

Series:
4 rising stocks — can they go higher: Promedicus, Xero, Novonix and CBA + is Westpac a buy?

Peter Switzer is joined by Julia Lee of Burman Invest, Michael Gable of Fairmont Equities, Jun Bei Liu of Tribeca Alpha Plus and Paul Rickard from the Switzer Report.

Series:
The treatments we have regarding COVID19 | The Check Up

Dr Ross takes a look at the beneficial treatments we can take after contracting COVID19.

Series:
5 stocks you have to own for the long-term + don’t ignore crypto + house prices slow in 2022?

Peter Switzer is joined by founder of Arminius Capital Marcel von Pfyffer, veteran investor Mark Carnegie, and founder of Century 21 Charles Tarbey.

Series:
1 22 23 24 25 26 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram